Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation

IF 6.7 1区 医学 Q1 NEUROSCIENCES NPJ Parkinson's Disease Pub Date : 2024-10-25 DOI:10.1038/s41531-024-00805-z
Hannah Oas, Lola Cook, Tae-Hwi Schwantes-An, Laurence E. Walsh, Anne-Marie Wills, Ignacio F. Mata, Martha A. Nance, James C. Beck, Anna Naito, Karen Marder, Roy N. Alcalay, Jennifer Verbrugge
{"title":"Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation","authors":"Hannah Oas, Lola Cook, Tae-Hwi Schwantes-An, Laurence E. Walsh, Anne-Marie Wills, Ignacio F. Mata, Martha A. Nance, James C. Beck, Anna Naito, Karen Marder, Roy N. Alcalay, Jennifer Verbrugge","doi":"10.1038/s41531-024-00805-z","DOIUrl":null,"url":null,"abstract":"<p>Genetic testing for Parkinson’s disease (PD) is infrequently performed due to perceptions of low utility. We investigated the personal utility in PD GENEration and how results lead to enrollment in additional research studies. Participants (<i>n</i> = 972) underwent genetic testing, results disclosure, genetic counseling, and completed a survey examining the perceived personal utility of their results and interest in participating in additional studies. Most participants found their genetic test results useful, including satisfying curiosity (81%), feeling good about helping the medical community (80%), and having information to share with family (77%). There were no significant differences in responses based on result type. Forty-five percent of participants expressed interest in participating in research studies; whereas 16% of participants confirmed enrollment. Our results suggest that participants find personal utility in genetic testing regardless of results. Although participants may be interested in enrolling in additional research, they may need support and resources.</p>","PeriodicalId":19706,"journal":{"name":"NPJ Parkinson's Disease","volume":"30 1","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Parkinson's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41531-024-00805-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Genetic testing for Parkinson’s disease (PD) is infrequently performed due to perceptions of low utility. We investigated the personal utility in PD GENEration and how results lead to enrollment in additional research studies. Participants (n = 972) underwent genetic testing, results disclosure, genetic counseling, and completed a survey examining the perceived personal utility of their results and interest in participating in additional studies. Most participants found their genetic test results useful, including satisfying curiosity (81%), feeling good about helping the medical community (80%), and having information to share with family (77%). There were no significant differences in responses based on result type. Forty-five percent of participants expressed interest in participating in research studies; whereas 16% of participants confirmed enrollment. Our results suggest that participants find personal utility in genetic testing regardless of results. Although participants may be interested in enrolling in additional research, they may need support and resources.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
参与者报告的帕金森病基因检测的个人效用以及参与临床试验的兴趣
帕金森病(Parkinson's disease,PD)基因检测因其效用较低而很少进行。我们调查了帕金森病基因检测的个人效用,以及检测结果如何导致患者加入其他研究。参与者(n = 972)接受了基因检测、结果披露、基因咨询,并完成了一项调查,检查了他们对检测结果个人效用的感知以及参与其他研究的兴趣。大多数参与者认为他们的基因检测结果是有用的,包括满足好奇心(81%)、为医学界提供帮助而感觉良好(80%)以及与家人分享信息(77%)。不同结果类型的回答没有明显差异。45%的参与者表示有兴趣参与研究;16%的参与者确认参加研究。我们的结果表明,无论结果如何,参与者都认为基因检测对个人有用。虽然参与者可能有兴趣参加其他研究,但他们可能需要支持和资源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
NPJ Parkinson's Disease
NPJ Parkinson's Disease Medicine-Neurology (clinical)
CiteScore
9.80
自引率
5.70%
发文量
156
审稿时长
11 weeks
期刊介绍: npj Parkinson's Disease is a comprehensive open access journal that covers a wide range of research areas related to Parkinson's disease. It publishes original studies in basic science, translational research, and clinical investigations. The journal is dedicated to advancing our understanding of Parkinson's disease by exploring various aspects such as anatomy, etiology, genetics, cellular and molecular physiology, neurophysiology, epidemiology, and therapeutic development. By providing free and immediate access to the scientific and Parkinson's disease community, npj Parkinson's Disease promotes collaboration and knowledge sharing among researchers and healthcare professionals.
期刊最新文献
Personalized progression modelling and prediction in Parkinson’s disease with a novel multi-modal graph approach Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson’s Disease MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity Awake versus asleep deep brain stimulation targeting the caudal zona incerta for essential tremor Accelerating Parkinson’s Disease drug development with federated learning approaches
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1